Serum free light chain assays not total light chain assays are the standard of care to assess Monoclonal Gammopathies

Overview of attention for article published in Revista Brasileira de Hematologia e Hemoterapia, January 2016

Altmetric Badge

About this Attention Score

Among the highest-scoring outputs from this source (#38 of 275)
Good Attention Score compared to outputs of the same age (73rd percentile)
High Attention Score compared to outputs of the same age and source (88th percentile)

So far, Altmetric has seen 18 tweets from 6 users, with an upper bound of 10,831 followers.

RT @BindingSiteHaem: 'Serum free light chain assays not total light chain assays are the standard of care to assess Monoclonal Gammopathies…

'Serum free light chain assays not total light chain assays are the standard of care to assess Monoclonal Gammopathies' https://t.co/FONEvoz8IN

'#Serum FLC assays not total light chain #assays are the standard of care to assess #Monoclonal Gammopathies' https://t.co/rdVuqMq82R

RT @BindingSiteHaem: sFLC assays not total light chain assays are the standard of care to assess Monoclonal Gammopathies' https://t.co/krAP…

This page shows the most recent tweets that mention this research output.

Click here to find out how to access more activity, including 14 additional tweets.